DP10017-Randomized, double-blind, placebo-controlled Phase III study of APD421 (amisulpride for IV injection) as combination prophylaxis against post-operative nausea and vomiting in high-risk patient

Administered By

Contributors

Start/End

  • March 1, 2015 - February 28, 2018